Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 OptiMark (Gadoversetamide) Injection
Company:  Tyco/Mallinckrodt Health Care
Application No.:  020937/S003, 020975/S003 & 20976/S003
Approval Date: 1/31/2003


Date created: January /29/2004

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.